Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record remains unavailable and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T15:48:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH website transition and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T14:44:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T15:15:16.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T14:32:13.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now presents a 403 Forbidden error page, with minimal site chrome showing '403' and basic header/footer. This replaces the previous study content with an access-denied notice.
    Difference
    22%
    Check dated 2026-09-20T19:46:41.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This is a minor system update with no changes to visible content.
    Difference
    0.0%
    Check dated 2026-08-30T07:01:24.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.